FAC-话题@MedSci

#FAC#

209篇内容 | 3482人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1956625, encodeId=7c1219566258f, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=JCO：治疗乳腺癌，紫杉醇周疗后再行FAC方案更有效, objectType=article, longId=19955, objectId=7463199556c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7463199556c, replyNumber=0, likeNumber=81, createdTime=2013-12-01, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7463199556c, moduleTitle=JCO：治疗乳腺癌，紫杉醇周疗后再行FAC方案更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7463199556c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956624, encodeId=e20219566247f, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究, objectType=article, longId=17915, objectId=dbba1e915b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbba1e915b2, replyNumber=0, likeNumber=73, createdTime=2013-10-01, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbba1e915b2, moduleTitle=A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbba1e915b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956623, encodeId=d5dc1956623f0, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=Cleft Palate Craniofac J：母亲暴露于多环芳烃子代易发唇裂, objectType=article, longId=17765, objectId=691c1e765a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=691c1e765a0, replyNumber=0, likeNumber=59, createdTime=2013-12-03, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=691c1e765a0, moduleTitle=Cleft Palate Craniofac J：母亲暴露于多环芳烃子代易发唇裂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=691c1e765a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956622, encodeId=3aa01956622d8, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=FDA批准tofacitinib治疗类风湿关节炎, objectType=article, longId=10908, objectId=07911090866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07911090866, replyNumber=0, likeNumber=68, createdTime=2013-10-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07911090866, moduleTitle=FDA批准tofacitinib治疗类风湿关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07911090866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956620, encodeId=335b1956620dc, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, objectType=article, longId=5996, objectId=78a6599680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a6599680, replyNumber=0, likeNumber=79, createdTime=2012-11-11, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a6599680, moduleTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a6599680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956621, encodeId=2ff519566214e, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效, objectType=article, longId=8928, objectId=d169892874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d169892874, replyNumber=0, likeNumber=70, createdTime=2013-07-09, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d169892874, moduleTitle=NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d169892874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956619, encodeId=2a711956619c9, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=特征因子(Eigenfactor)的背景及部分性质, objectType=article, longId=314, objectId=65c73148a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65c73148a, replyNumber=0, likeNumber=74, createdTime=2010-08-09, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65c73148a, moduleTitle=特征因子(Eigenfactor)的背景及部分性质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65c73148a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956618, encodeId=06bf1956618b7, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=科学杂志排名，Impact Factor 对比 PageRank, objectType=article, longId=227, objectId=59e322e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59e322e5a, replyNumber=0, likeNumber=63, createdTime=2009-09-06, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59e322e5a, moduleTitle=科学杂志排名，Impact Factor 对比 PageRank, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59e322e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956617, encodeId=9221195661e22, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, objectTitle=《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子), objectType=article, longId=169, objectId=7387169d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7387169d6, replyNumber=0, likeNumber=87, createdTime=2009-11-19, rootId=0, userName=夏天与十三菇凉, userId=eb8e2500096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7387169d6, moduleTitle=《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7387169d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FAC

2020-05-29

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

JCO：治疗乳腺癌，紫杉醇周疗后再行FAC方案更有效

2013-12-01

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

A&R: 接受甲氨蝶呤治疗的类风湿关节炎患者合用Tofacitinib（CP-690,550）的临床随机研究

2013-10-01

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

Cleft Palate Craniofac J：母亲暴露于多环芳烃子代易发唇裂

2013-12-03

爆笑小医 (审核中...)

前往app查看评论内容

#FAC#

FDA批准tofacitinib治疗类风湿关节炎

2013-10-08

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决

2012-11-11

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

NEJM：新药Tofacitinib具有治疗类风湿性关节炎的疗效

2013-07-09

docwu2019 (审核中...)

前往app查看评论内容

#FAC#

特征因子(Eigenfactor)的背景及部分性质

2010-08-09

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

科学杂志排名，Impact Factor 对比 PageRank

2009-09-06

夏天与十三菇凉 (审核中...)

前往app查看评论内容

#FAC#

《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子)

2009-11-19

科室
- - 订阅+
  - 更多科室
工具
服务